Why the study?
Do antihypertensive treatment strategies targeting both average blood pressure levels and blood pressure variability optimize cardiovascular protection in patients with hypertension and diabetes?
Do antihypertensive treatment strategies targeting both average blood pressure levels and blood pressure variability optimize cardiovascular protection in patients with hypertension and diabetes?
This review evaluates the prognostic importance of blood pressure variability and average blood pressure levels for cardiovascular protection in diabetic patients.
No takes yet. Share an insight, caveat, or question.
BP variability may inform CV risk beyond mean levels in diabetes; leaves open whether targeting it improves outcomes.
Parati et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: